BSE filing, NSE: AGARWALEYE. Summary written from the filing by ALFA Finder's alert engine.
Dr. Agarwals Health Care Ltd: key numbers
- Share price
- ₹511.70
- Market cap
- ₹16,222 Cr
- Revenue (annual)
- ₹2,080 Cr
- Net profit (annual)
- ₹133.2 Cr
- P/E (TTM)
- 109.3×Sector 54.5×
- Promoter holding
- 32.33%-0.01% QoQ
- FII holding
- 49.56%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dr. Agarwals Health Care Ltd
All →Dr. Agarwals Health Care Other Announcement
Dr. Agarwal's Health Care submitted ICRA's monitoring agency report for the quarter ended September 30, 2026. ICRA reports no material deviation in IPO proceeds utilisation.
Dr. Agarwals Health Care Employee Stock Options
Dr. Agarwal's Health Care allotted 54,728 equity shares to employees on exercise of ESOP 2022 options. Paid-up capital rose to 31,70,99,111 shares, with no cash consideration stated.
Dr. Agarwals Health Care Earnings Call Transcript: Key Takeaways
Q2 FY27 revenue ₹655 Cr (+31.4% YoY) and PAT ₹57 Cr (+55.8%), network-led growth; India EBITDA margin flat near 28%.
Dr. Agarwals Health Care Management Change
Dr Agarwals Health Care reports Mr. Amar Agarwal's redesignation from Chairman and Non-Executive Director to Executive Director, effective 1 November 2026. The change was approved at a board meeting held on 5 November 2026.
Dr. Agarwals Health Care Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹655 Cr (+31.4% YoY) and PAT ₹57 Cr (+55.8%). H1 FY27 revenue ₹1,269 Cr (+28.7%), PAT ₹112 Cr (+50.1%). Strategy is aggressive facility expansion, with 65 FY27E additions.
Dr. Agarwals Health Care Financial Results
Dr. Agarwal's H1 FY27 revenue rose 28.7% to Rs 1,269 crore; PAT rose 50.1% to Rs 112 crore. Amar Agarwal's executive chairman appointment awaits postal ballot approval.
Other management change announcements
All →Kanishk Aluminium India Management Change
Kanishk Aluminium's CFO Nitin Pandya resigned, effective close of business November 2, 2026. The filing is a Regulation 30 KMP change intimation with the resignation letter attached.
Accord Synergy Management Change
Accord Synergy's Company Secretary and Compliance Officer, Drashti Gandhi, has resigned effective November 30, 2026. The resignation follows recent management changes and a takeover.
Gyan Developers & Builders Management Change
Gyan Developers & Builders appointed Neeraj Dixit as Non-Executive Independent Director for a 60-month term, effective November 5, 2026. The filing confirms he is not debarred and is not disqualified under Section 164.
Antony Waste Handling Cell Management Change
Antony Waste Handling Cell noted the completion of three independent directors' tenures on 11 December 2026. It also approved three new Independent Directors from 12 December 2026, subject to shareholder approval.
- Execution
- Appointments of 5 consecutive years from 2026-12-12
NCC Management Change
NCC Limited re-appointed three executive directors, A V Ranga Raju Alluri as MD and two Whole-time Directors, effective 1 April 2027 for 60 months. Only a board-level leadership renewal is disclosed, with no financial amount.
- Execution
- Re-appointment term of 60 months from 2027-04-01
Hindustan Composites Management Change
Hindustan Composites appointed Vinay Sarin as CEO and KMP from 6 November 2026, after his director resignation. Shareholder approval is sought for his Whole-Time Director appointment.